Suppr超能文献

孕早期与孕晚期首次葡萄糖筛查试验结果之间的相关性。

Correlation between first- and early third-trimester glucose screening test results.

作者信息

Nahum G G, Huffaker B J

机构信息

Department of Obstetrics and Gynecology, Kaiser Foundation Hospital, Los Angeles, California.

出版信息

Obstet Gynecol. 1990 Oct;76(4):709-13.

PMID:2216208
Abstract

One hundred twenty-four normal gravidas had paired first- and early third-trimester (26-32 weeks) 1-hour oral glucose screening tests performed. First-trimester oral glucose screening test values correlated significantly with third-trimester glucose screening test results for the entire population, for whites and non-whites, and for normal-weight and obese patients. First-trimester oral glucose screening test values at or below 110 mg/dL were seldom associated with third-trimester oral glucose screening test results at or above 135 mg/dL and were not associated with abnormal 3-hour glucose tolerance test (GTT) results. Nine of the gravidas (7.3%) were diagnosed with gestational diabetes mellitus during the third trimester, all of whom had first-trimester glucose screening test results above 110 mg/dL. The difference in incidence of gestational diabetes mellitus between gravidas having first-trimester glucose screening test results at or below 110 mg/dL (0%) and those having values above 110 mg/dL (16.4%) was highly significant (P less than .0001). For patients with first-trimester glucose screening test values at or below 110 mg/dL, third-trimester glucose screening may be unnecessary. In contrast, for gravidas having first-trimester glucose screening test results at or above 135 mg/dL, there is a high positive predictive value for elevated repeat glucose screening test results during the early third trimester. Patients having elevated first-trimester glucose screening values at or above 140 mg/dL are at particularly high risk for elevated glucose screening test results later in pregnancy and should forego repeat 1-hour third-trimester glucose screening in favor of a direct third-trimester 3-hour GTT.

摘要

对124名正常孕妇进行了孕早期(妊娠13周之前)和孕晚期早期(26 - 32周)的1小时口服葡萄糖筛查试验。对于全体孕妇、白种人和非白种人孕妇,以及体重正常和肥胖的孕妇,孕早期口服葡萄糖筛查试验值与孕晚期葡萄糖筛查试验结果显著相关。孕早期口服葡萄糖筛查试验值在110mg/dL及以下的情况很少与孕晚期口服葡萄糖筛查试验结果在135mg/dL及以上相关,且与异常的3小时葡萄糖耐量试验(GTT)结果无关。9名孕妇(7.3%)在孕晚期被诊断为妊娠期糖尿病,她们所有人的孕早期葡萄糖筛查试验结果均高于110mg/dL。孕早期葡萄糖筛查试验结果在110mg/dL及以下的孕妇(0%)与结果高于110mg/dL的孕妇(16.4%)之间妊娠期糖尿病的发病率差异非常显著(P小于0.0001)。对于孕早期葡萄糖筛查试验值在110mg/dL及以下的患者,孕晚期葡萄糖筛查可能没有必要。相比之下,对于孕早期葡萄糖筛查试验结果在135mg/dL及以上的孕妇,孕晚期早期重复葡萄糖筛查试验结果升高的阳性预测值较高。孕早期葡萄糖筛查值在140mg/dL及以上的孕妇在妊娠后期葡萄糖筛查试验结果升高的风险特别高,应放弃孕晚期重复的1小时葡萄糖筛查,而直接进行孕晚期3小时GTT。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验